Medikit Co.,Ltd. (TYO:7749)
2,873.00
-16.00 (-0.55%)
Nov 26, 2025, 12:30 PM JST
Medikit Revenue
Medikit had revenue of 6.03B JPY in the quarter ending September 30, 2025, with 6.61% growth. This brings the company's revenue in the last twelve months to 23.19B, up 4.03% year-over-year. In the fiscal year ending March 31, 2025, Medikit had annual revenue of 22.55B with 3.22% growth.
Revenue (ttm)
23.19B
Revenue Growth
+4.03%
P/S Ratio
1.82
Revenue / Employee
23.45M
Employees
989
Market Cap
42.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 22.55B | 703.00M | 3.22% |
| Mar 31, 2024 | 21.85B | 243.00M | 1.12% |
| Mar 31, 2023 | 21.61B | 1.48B | 7.34% |
| Mar 31, 2022 | 20.13B | 818.00M | 4.24% |
| Mar 31, 2021 | 19.31B | -581.00M | -2.92% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |